Page last updated: 2024-11-06

24-methylene cycloartanol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

24-methylene cycloartanol: structure given in first source; RN given refers to 3beta-isomer; RN for compound without isomeric designation not avail 11/90 [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

24-methylenecycloartanol : A pentacyclic triterpenoid that is (9beta)-24-methylene-9,19-cyclolanostane which carries a hydroxy group at position 3beta. It is isolated from several plant species including Euphorbia, Epidendrum, Psychotria and Sideritis. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

FloraRankFlora DefinitionFamilyFamily Definition
EuphorbiagenusA large plant genus of the family EUPHORBIACEAE, order Euphorbiales, subclass Rosidae. They have a milky sap and a female flower consisting of a single pistil surrounded by numerous male flowers of one stamen each. Euphorbia hirta is rarely called milkweed but that name is normally used for ASCLEPIAS.[MeSH]EuphorbiaceaeThe spurge family of flowering plants in the order Malpighiales. The family consists of annual and perennial herbs and woody shrubs or trees. Members contain securinine.[MeSH]

Cross-References

ID SourceID
PubMed CID94204
CHEMBL ID376350
CHEBI ID1307
SCHEMBL ID1653320
MeSH IDM0181367

Synonyms (32)

Synonym
24-methylene-cycloartanol
24-methylene-9beta,19-cyclo-lanostan-3beta-ol
24-methylenecycloartanol
C08830
24-methylidenecycloartanol
1449-09-8
4alpha,4beta,14alpha-trimethyl-9beta,19-cyclo-5alpha-ergost-24(24(1))-en-3beta-ol
9,19-cyclolanostan-3-o1, 24-methylene-, (3beta)-
24(28)-methylenecycloartanol
chebi:1307 ,
CHEMBL376350 ,
(3|a,9|a)-24-methylidene-9,19-cyclolanostan-3-ol
AC1L3RQE ,
fi34181g3x ,
24-methylene cycloartanol
unii-fi34181g3x
SCHEMBL1653320
24-methylenecycloartan-3beta-ol
24-methylene-9beta,19-cyclolanostan-3beta-ol
(3beta,9beta)-24-methylene-9,19-cyclolanostan-3-ol
24-methylenecycloartan-3-ol
bdbm50478903
AKOS032948480
DTXSID90932442
24-methylidene-9,19-cyclolanostan-3-ol
Q27105441
3.beta.-hydroxy-24-methylenecycloartane
cycloartanol, 24-methylene-
(1s,3r,6s,8r,11s,12s,15r,16r)-7,7,12,16-tetramethyl-15-[(2r)-6-methyl-5-methylideneheptan-2-yl]pentacyclo[9.7.0.01,3.03,8.012,16]octadecan-6-ol
9,19-cyclolanostan-3-ol, 24-methylene-, (3beta)-
GLXC-16620
FS-10372
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
plant metaboliteAny eukaryotic metabolite produced during a metabolic reaction in plants, the kingdom that include flowering plants, conifers and other gymnosperms.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
pentacyclic triterpenoid
3beta-hydroxy steroidA 3-hydroxy steroid in which the 3-hydroxy substituent is in the beta-position.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (9)

Assay IDTitleYearJournalArticle
AID288762Inhibition of TPA-induced Epstein-Barr virus early antigen activation assessed as EBV-EA induction in Raji cells at 3.2 nM after 48 hrs relative to TPA2007Journal of natural products, Jun, Volume: 70, Issue:6
Cancer chemopreventive effects of cycloartane-type and related triterpenoids in in vitro and in vivo models.
AID288764Inhibition of TPA-induced Epstein-Barr virus early antigen activation in Raji cells after 48 hrs2007Journal of natural products, Jun, Volume: 70, Issue:6
Cancer chemopreventive effects of cycloartane-type and related triterpenoids in in vitro and in vivo models.
AID288761Inhibition of TPA-induced Epstein-Barr virus early antigen activation assessed as EBV-EA induction in Raji cells at 32 nM after 48 hrs relative to TPA2007Journal of natural products, Jun, Volume: 70, Issue:6
Cancer chemopreventive effects of cycloartane-type and related triterpenoids in in vitro and in vivo models.
AID288760Inhibition of TPA-induced Epstein-Barr virus early antigen activation assessed as EBV-EA induction in Raji cells at 320 nM after 48 hrs relative to TPA2007Journal of natural products, Jun, Volume: 70, Issue:6
Cancer chemopreventive effects of cycloartane-type and related triterpenoids in in vitro and in vivo models.
AID379279Inhibition of HIV1 protease2000Journal of natural products, Feb, Volume: 63, Issue:2
Inhibitory effects on HIV-1 protease of constituents from the wood of Xanthoceras sorbifolia.
AID288763Inhibition of TPA-induced Epstein-Barr virus early antigen activation assessed as EBV-EA induction in Raji cells at 0.32 nM after 48 hrs relative to TPA2007Journal of natural products, Jun, Volume: 70, Issue:6
Cancer chemopreventive effects of cycloartane-type and related triterpenoids in in vitro and in vivo models.
AID288765Cell viability of Raji cells at 320 nM2007Journal of natural products, Jun, Volume: 70, Issue:6
Cancer chemopreventive effects of cycloartane-type and related triterpenoids in in vitro and in vivo models.
AID288766Scavenging activity against NO generation in human Chang liver cells assessed as inhibition of NOR1-activation at 350 nM relative to NOR12007Journal of natural products, Jun, Volume: 70, Issue:6
Cancer chemopreventive effects of cycloartane-type and related triterpenoids in in vitro and in vivo models.
AID379280Inhibition of HIV1 protease at 100 ug/ml2000Journal of natural products, Feb, Volume: 63, Issue:2
Inhibitory effects on HIV-1 protease of constituents from the wood of Xanthoceras sorbifolia.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (9)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (11.11)18.2507
2000's5 (55.56)29.6817
2010's3 (33.33)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.21

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.21 (24.57)
Research Supply Index2.40 (2.92)
Research Growth Index4.60 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.21)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (11.11%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other8 (88.89%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]